FacebookXLinkedInInstagram

Depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram

By |2020-10-02T11:43:24-07:00February 6th, 2020|Brief Bulletins from the Field, Featured|

In a recent study, researchers described treatment-emergent sexual dysfunction (TESD) and tolerability following a switch from selective serotonin reuptake inhibitor (SSRI: citalopram, paroxetine, or sertraline) monotherapy to vortioxetine or escitalopram monotherapy in adults with well-treated major depressive disorder (MDD) and SSRI-induced sexual dysfunction. The study was published in CNS Spectrums. [...]

Read More
 0

AFSP: Can Ketamine Rapidly Reduce Suicidal Ideation?

By |2021-11-11T17:07:05-08:00June 22nd, 2017|Brief Bulletins from the Field, We Know Psychiatry|

This work was sponsored by a Young Investigator Grant from the American Foundation for Suicide Prevention (AFSP) BACKGROUND Suicide is preventable, yet still remains a worldwide cause of death in part due to a lack of available medical interventions that can work during a suicidal crisis. Most potentially helpful medications [...]

Read More
 0

Title

Go to Top